[1]Patent:US2008/207573,2008,A1.Locationinpatent:Page/Pagecolumn87-88
[1]JournalofMedicinalChemistry,2010,vol.53,p.3227-3246
[1]Patent:US2019/55264,2019,A1.Locationinpatent:Paragraph0896
10138-10-0
123-25-1
1310381-54-4
1217800-69-5
141-03-7
15026-17-2
1175793-77-7 | 3-(M-Tolyl)-1h-indazol-5-amine | AA0099GS | MFCD11893549
1049749-93-0 | 2-Methoxybutanohydrazide hydrochloride | AA0099UL | MFCD08559375
131-72-6 | DINOCAP | AA009AHS | MFCD00054268
1401163-85-6 | 2-(2,2,2-Trifluoroethoxy)pyrimidine-5-boronic acid | AA009AWK | MFCD07375137
133220-30-1 | INDANOFAN | AA009B4H | MFCD03427428
135026-17-4 | Ethyl 2-amino-4-(trifluoromethyl)oxazole-5-carboxylate | AA009BH0 | MFCD09909738
137795-17-6 | (±)WIN 55212 (mesylate) | AA009BJQ
122801-61-0 | 2-(4-Trifluoromethylphenyl)phenol | AA009BPQ | MFCD06802852
129605-53-4 | (2S)-2-((5S)-1-[(9H-Fluoren-9-yl-methoxy)carbonyl]-6-oxo-1,7-diazaspiro[4.4]non-7-yl)-4-methylpentanoic acid | AA009BZV | MFCD00273481
1262036-50-9 | Ly2886721 | AA009CA4 | MFCD22124078